Second temple and Roman period in historical work of Abraham ibn Daud

The thesis contains a Czech translation of Hebrew historiographical monographs Zikhron divre Romi and Divre Malkhe Yisra'el be-Bayit sheni by the Jewish historian Abraham ibn Daud (ca 1110 - ca 1180). The translation is accompanied by a commentary and an introduction divided into three chapters

MOESM9 of Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

Additional file 9: Figure S1. qRT-PCR analysis of selected genes in TMZ-treated cells. a The relative gene expression ratios (fold-change) of stem cell markers CD133, OCT4, SOX2, and NANOG. b The relative gene expression ratio (fold-change) of MGMT. Gene expression fold-change values were derived by 2-ΔΔCT method (expressed as ratios relative to control values after normalization to the internal control TBP). TBP – TATA-binding protein; CD133 – prominin 1; OCT4 – POU class 5 homeobox 1; SOX2 – SRY (sex determining region Y)-box 2; NANOG – Nanog homeobox; MGMT – O-6-methylguanine-DNA methyltransferase

MOESM8 of Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

Additional file 8: Table S8. Table S8. A list of genes/proteins, which were experimentally shown to increase/reduce the sensitivity of tumour cells to temozolomide (TMZ) treatment

MOESM3 of Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

Additional file 3: Table S3. Table S3. A list of CCAs/NCCAs and their copy number variation in T98G and T98GTMZ cells

MOESM7 of Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

Additional file 7: Table S7. Table S7. A list of annotated genes in gained 4p16.1-q26 region retrieved using a the DAVID bioinformatics resource or b the NCBI Map Viewer. These lists of annotated genes were cross-checked with a manually curated list of published proteins/miRNAs that were shown to contribute to TMZ resistance (see Suppl. Table S8), and hits were marked with colour

MOESM5 of Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

Additional file 5: Table S5. Table S5. A list of CCAs/NCCAs and their copy number variation in C6, C6TMZ, C6R1, and C6R2TMZ cells